Experimental & Molecular Medicine

Experimental & Molecular Medicine re-launches as open access

Experimental & Molecular Medicine (EMM) has re-launched on as a fully open-access title. Co-published by Nature Publishing Group (NPG) and the Korean Society for Biochemistry and Molecular Biology (KSBMB), EMM aims to publish the latest and most important advances in genetic, molecular and cellular studies of human physiology and diseases. 

'We are very excited to commence this new partnership with NPG,' said Dae-Myung Jue, editor-in-chief of EMM. 'We expect combining the publishing expertise of NPG with the fast-growing research in the field, especially in East Asia, will provide an ideal platform to address various medical problems that we face today.' 

'The formation of the partnership between NPG and the KSBMB means that EMM, Korea’s first biochemistry journal, is also the first Korean journal to join the NPG Asia-Pacific journals programme,' said Dugald McGlashan, publisher of NPG's Asia-Pacific Academic Journals.


Publishing platforms are the true drivers of digital content within the scholarly industry. Tim Gillett gets up close


As the scholarly publishing world adopts altmetrics, the ways in which the data is used are developing fast, reports Rebecca Pool


For academic libraries, the future is cloud-based. Here, Scott Livingston, OCLC’s executive director for market strategy, shares his outlook – while we look at a new community project to develop a cloud-based library services platform


After learning to fly a plane, and then teaching German business executives to speak English, London Info International’s Philip Ditchfield also worked in pharma and publishing sales